Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
52.36
+3.60 (7.38%)
At close: Jun 18, 2026, 4:00 PM EDT
51.32
-1.04 (-1.99%)
After-hours: Jun 18, 2026, 6:08 PM EDT
Spruce Biosciences Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
14
Market Cap
144.11M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 4.91M | -5.18M | -51.32% |
| Dec 31, 2023 | 10.09M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ADC Therapeutics | 79.18M |
| Spero Therapeutics | 61.19M |
| Alpha Cognition | 10.83M |
| NRx Pharmaceuticals | 2.29M |
| Molecular Partners AG | 856.30K |
| NeOnc Technologies Holdings | 39.99K |
| Genelux | 8.00K |
| Fractyl Health | 3.00K |
SPRB News
- 3 days ago - Spruce Biosciences initiated with a Buy at Guggenheim - TheFly
- 4 days ago - Spruce Biosciences names Eric Jordan VP, marketing, Tina Gullotta VP, finance - TheFly
- 4 days ago - Spruce Biosciences Appoints Eric Jordan as Vice President, Marketing and Tina Gullotta as Vice President, Finance and Corporate Controller - Business Wire
- 11 days ago - Spruce Biosciences initiated with a Buy at JonesResearch - TheFly
- 11 days ago - Spruce says long-term TA-ERT data presented at MPS Symposium - TheFly
- 11 days ago - Spruce Biosciences Announces Long-Term Tralesinidase Alfa Enzyme Replacement Therapy Data in Sanfilippo Syndrome Type B (MPS IIIB) Presented at the 18th International MPS Symposium - Business Wire
- 15 days ago - Spruce Biosciences Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 18 days ago - Spruce Biosciences price target lowered to $150 from $200 at H.C. Wainwright - TheFly